Prescription drug-focused health IT start-up raises $90M

Blink Health, a health IT start-up focused on improving access to prescription medications, raised $90 million in a Series B financing round. The start-up now has a total of $165 million in financing.

Advertisement

Blink Health’s technology platform allows consumers to access the medications via the internet. It links consumers to 57,000 pharmacies nationwide, and allows them to buy generic medications online and pick them up from a local retailer for up to 90 percent off the average retail price.

Since its launch in 2014, the company has grown its active users to more than one million per month. The company also offers branded drug programs, including an insulin discount program with Indianapolis-based Eli Lilly. Blink Health will use the new funds to drive innovations.

More articles on health IT:
5 things data scientists want hospital leaders to know
Metro Community Provider Network agrees to $400k HIPAA settlement
10 guidelines for ethical data research

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.